Waters Corporation WAT

433.54 3.24 0.75% as of 25 Sep
Market cap
$42.3B
P/E
108×
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month

Waters Corporation (WAT) EV/EBITDA

As of 25 September 2026, Waters Corporation (WAT) trades at a EV/EBITDA of 49.8×. Over the past ten years it has ranged from 12.9× (February 2016) to 49.8× (September 2026) — the current reading is the highest in ten years. That is above the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 22.8× (0.59%)
FY2024 22.9× 5.62%
FY2023 21.7× (0.05%)
FY2022 21.7× (13.43%)
FY2021 25.1× 19.76%
FY2020 20.9× (0.12%)
FY2019 20.9× 27.47%
FY2018 16.4× (10.59%)
FY2017 18.4× 33.80%
FY2016 13.7× (11.24%)

Quarterly

Period EV/EBITDA Change
Jun 2026 43.7× 46.34%
Mar 2026 29.8× 31.12%
Dec 2025 22.8× 27.45%
Sep 2025 17.9× (13.98%)
42 more quarters

Against its own ten years

Low 12.9× High 49.8×
Ten-year median 19.1×
Current reading's percentile 100

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
IQV IQVIA Holdings Inc. compare 17.3×
MTD Mettler-Toledo International, Inc. compare 24.9×
IDXX IDEXX Laboratories, Inc. compare 25.6×
A Agilent Technologies, Inc. compare 26.5×
ILMN Illumina, Inc. compare 36.0×
WAT Waters Corporation 49.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on WAT